Follow
William Douglas Cress
William Douglas Cress
Verified email at moffitt.org
Title
Cited by
Cited by
Year
Expression of transcription factor E2F1 induces quiescent cells to enter S phase
DG Johnson, JK Schwarz, WD Cress, JR Nevins
Nature 365 (6444), 349-352, 1993
12961993
Histone deacetylases, transcriptional control, and cancer
WD Cress, E Seto
Journal of cellular physiology 184 (1), 1-16, 2000
9052000
Critical structural elements of the VP16 transcriptional activation domain
WD Cress, SJ Triezenberg
Science 251 (4989), 87-90, 1991
5861991
Interactions between E2F1 and SirT1 regulate apoptotic response to DNA damage
C Wang, L Chen, X Hou, Z Li, N Kabra, Y Ma, S Nemoto, T Finkel, W Gu, ...
Nature cell biology 8 (9), 1025-1031, 2006
5512006
Role of Stat3 in regulating p53 expression and function
G Niu, KL Wright, Y Ma, GM Wright, M Huang, R Irby, J Briggs, J Karras, ...
Molecular and cellular biology 25 (17), 7432-7440, 2005
4982005
Reduced binding of TFIID to transcriptionally compromised mutants of VP16
CJ Ingles, M Shales, WD Cress, SJ Triezenberg, J Greenblatt
Nature 351 (6327), 588-590, 1991
4151991
Selective inhibition of activated but not basal transcription by the acidic activation domain of VP16: evidence for transcriptional adaptors
SL Berger, WD Cress, A Cress, SJ Triezenberg, L Guarente
Cell 61 (7), 1199-1208, 1990
4071990
Oncogenic capacity of the E2F1 gene.
DG Johnson, WD Cress, L Jakoi, JR Nevins
Proceedings of the National Academy of Sciences 91 (26), 12823-12827, 1994
3621994
Differential association of STK11 and TP53 with KRAS mutation-associated gene expression, proliferation and immune surveillance in lung adenocarcinoma
MB Schabath, EA Welsh, WJ Fulp, L Chen, JK Teer, ZJ Thompson, ...
Oncogene 35 (24), 3209-3216, 2016
3202016
Mcl-1 regulates survival and sensitivity to diverse apoptotic stimuli in human non-small cell lung cancer cells
L Song, D Coppola, S Livingston, WD Cress, EB Haura
Cancer biology & therapy 4 (3), 267-276, 2005
2892005
Signal transducer and activator of transcription 3 is required for hypoxia-inducible factor-1α RNA expression in both tumor cells and tumor-associated myeloid cells
G Niu, J Briggs, J Deng, Y Ma, H Lee, M Kortylewski, M Kujawski, H Kay, ...
Molecular Cancer Research 6 (7), 1099-1105, 2008
2412008
TGF-β–inducible microRNA-183 silences tumor-associated natural killer cells
SS Donatelli, JM Zhou, DL Gilvary, EA Eksioglu, X Chen, WD Cress, ...
Proceedings of the National Academy of Sciences 111 (11), 4203-4208, 2014
2372014
cAMP/CREB-regulated LINC00473 marks LKB1-inactivated lung cancer and mediates tumor growth
Z Chen, JL Li, S Lin, C Cao, NT Gimbrone, R Yang, DA Fu, MB Carper, ...
The Journal of clinical investigation 126 (6), 2267-2279, 2016
2102016
CD4+ T cells from elite controllers resist HIV-1 infection by selective upregulation of p21
H Chen, C Li, J Huang, T Cung, K Seiss, J Beamon, MF Carrington, ...
The Journal of clinical investigation 121 (4), 1549-1560, 2011
2102011
Direct repression of the Mcl-1 promoter by E2F1
R Croxton, Y Ma, L Song, EB Haura, WD Cress
Oncogene 21 (9), 1359-1369, 2002
2002002
Subunit composition determines E2F DNA-binding site specificity
Y Tao, RF Kassatly, WD Cress, JM Horowitz
Molecular and cellular biology, 1997
1731997
Deregulated expression of LRBA facilitates cancer cell growth
JW Wang, JJ Gamsby, SL Highfill, LB Mora, GC Bloom, TJ Yeatman, ...
Oncogene 23 (23), 4089-4097, 2004
1652004
A genetic analysis of the E2F1 gene distinguishes regulation by Rb, p107, and adenovirus E4
WD Cress, DG Johnson, JR Nevins
Molecular and cellular biology 13 (10), 6314-6325, 1993
1601993
Flavopiridol-induced apoptosis is mediated through up-regulation of E2F1 and repression of Mcl-1
Y Ma, WD Cress, EB Haura
Molecular cancer therapeutics 2 (1), 73-81, 2003
1362003
Racial and ethnic differences in the epidemiology and genomics of lung cancer
MB Schabath, WD Cress, T Muņoz-Antonia
Cancer Control 23 (4), 338-346, 2016
1332016
The system can't perform the operation now. Try again later.
Articles 1–20